A mouse sperm decapacitation factor receptor is phosphatidylethanolamine-binding protein 1
A mouse sperm decapacitation factor receptor is phosphatidylethanolamine-binding protein 1
复制标题
DOI:
10.1530/rep.1.00792
复制
发表时间:
2005-10-01
期刊:
影响因子:
3.8
通讯作者:
Fraser, LR
中科院分区:
文献类型:
--
作者:
Gibbons, R;Adeoya-Osiguwa, SA;Fraser, LR
Capacitation is a pivotal event for mammalian spermatozoa, involving the loss of surface proteins known as decapacitation factors (DF) and consequent acquisition of fertilizing ability. Earlier studies showed that a mouse sperm DF binds to a receptor, DF-R, whose attachment to the sperm plasma membrane appears to involve a glycosylphosphatidylinositol (GPl) anchor. In the present study, purification and subsequent sequencing of DF-R has identified this similar to 23 kDa protein as phosphatidylethanolamine-binding protein 1 (PEBP 1). To obtain functional evidence that supports sequence homology data, purified recombinant PEBP 1 and PEBP 2 were evaluated for biological activity. While PEBP 1 was able to remove DF activity in solution at concentrations above similar to 1 nmol/l, PEBP 2 was ineffective, even at 600 nmol/l; this confirmed that DF-R is PEBP 1. Anti-PEBP 1 antiserum recognized recombinant PEBP 1 and a similar to 23 kDa protein in both mouse and human sperm lysates. Immunolocalization studies revealed that DF-R/PEBP 1 is located on the acrosomal cap, the post-acrosomal region and the flagellum of both mouse and human spermatozoa, with epitope accessibility being capacitation state-dependent and reversible. Treatment of cells with a phospholipase able to cleave GPl anchors essentially abolished immunostaining, thus confirming the extracellular location of DF-R/PEBP 1. We suggest that DF-R/PEBP 1 plays its fundamental role in capacitation by causing alterations in the sperm plasma membrane in both head and flagellum, with functional consequences for membrane-associated proteins. Obtaining more detail about DF DF-R interactions could lead to useful applications in both fertility treatments and new contraceptive approaches.